Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.44 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 2/20 | 0.44 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanyl Glutamine SCHEMBL133886 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL31140886 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL28215332 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL1009705 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL4274839 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL8813935 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL133887 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL29804717 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518502 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518470 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031666-A | Application of recombinant DL-endopeptidase and metabolite thereof in preparation of medicine for preventing premature infant late-onset septicemia | 南方医科大学珠江医院 | 2026-05-15 | — | — | CN | claimed |
| CN-110702819-B | Method for separating and measuring polypeptide chiral isomers containing multiple chiral centers by using high performance liquid chromatography | 浙江美测医药科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| EP-0635026-B1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | IAF BIOCHEM INT (CA) | 1999-11-10 | — | — | EP | claimed |
| WO-1997005889-A1 | NON-SPECIFIC VACCINATION BY D-AMINO-ACID CONTAINING COMPOUNDS | SLESAREV VLADIMIR I (US) | 1997-02-20 | — | — | WO | claimed |
| CN-122031666-A | Application of recombinant DL-endopeptidase and metabolite thereof in preparation of medicine for preventing premature infant late-onset septicemia | 南方医科大学珠江医院 | 2026-05-15 | — | — | CN | disclosed |
| EP-4739700-A1 | RESPIRATORY SYNCYTIAL VIRUS MUTANTS, FUSION PEPTIDES, PARTICLES, NUCLEIC ACIDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE | Emory University (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025089217-A1 | COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE | 株式会社ヤクルト本社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025075887-A2 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING HEPATITIS C VIRAL INFECTIONS | EMORY UNIVERSITY (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025014822-A1 | RESPIRATORY SYNCYTIAL VIRUS MUTANTS, FUSION PEPTIDES, PARTICLES, NUCLEIC ACIDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE | EMORY UNIVERSITY (US) | 2025-01-16 | — | — | WO | disclosed |
| US-20240238361-A1 | METHODS OF TREATING FIBROSIS AND HYPOXIA-ASSOCIATED DAMAGE TO PERIPHERAL NERVES | Temple Therapeutics BV (NL) | 2024-07-18 | — | — | US | disclosed |
| WO-2024073697-A1 | RSV VACCINES WITH TRUNCATED G-PROTEIN MUCIN DOMAINS | EMORY UNIVERSITY (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4333828-A1 | METHODS OF TREATING FIBROSIS AND HYPOXIA-ASSOCIATED DAMAGE TO PERIPHERAL NERVES | Temple Therapeutics BV (NL) | 2024-03-13 | — | — | EP | disclosed |
| US-20220127590-A1 | STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA | UNIV ROCKEFELLER (US) | 2022-04-28 | — | — | US | disclosed |
| CN-114381470-A | Artificial nucleic acid molecules | 库瑞瓦格股份公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-110702819-A | Method for separating and measuring polypeptide chiral isomers containing multiple chiral centers by using high performance liquid chromatography | 浙江美测医药科技有限公司 | 2020-01-17 | — | — | CN | disclosed |
| CN-110392577-A | RNA vaccines and immune checkpoint inhibitors for combination anti-cancer therapy | 库尔维科公司 | 2019-10-29 | — | — | CN | disclosed |
| CN-110352071-A | Lipidic nanoparticles mRNA vaccine | 库瑞瓦格股份公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-103360462-B | Refining method of alanyl-glutamine crude drug | SHANDONG QIDU PHARMACEUTICAL | 2015-06-24 | — | — | CN | disclosed |
| WO-1990006322-A1 | PEPTIDOGLUCAN DIMERS, PROCESS FOR PRODUCING THEM AND THEIR USE AS IMMUNOMODULATORS | HELOPHARM W. PETRIK GMBH & CO., KG (DE) | 1990-06-14 | — | — | WO | disclosed |
| EP-0006068-B1 | COMPOUNDS OF THE MURAMYL-PEPTIDE TYPE AND MEDICINES CONTAINING THEM | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-09-21 | — | — | EP | disclosed |